Standout Papers

Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 2015 2026 2018 2022 827
  1. Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 (2015)
    Jing Lü, Yimin Qian et al. Chemistry & Biology
  2. PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer (2016)
    Kanak Raina, Jing Lü et al. Proceedings of the National Academy of Sciences
  3. The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study (2017)
    George M. Burslem, Blake E. Smith et al. Cell chemical biology

Immediate Impact

2 by Nobel laureates 29 from Science/Nature 81 standout
Sub-graph 1 of 16

Citing Papers

Targeting protein–ligand neosurfaces with a generalizable deep learning tool
2025 StandoutNature
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
3 intermediate papers

Works of Andrew P. Crew being referenced

Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
2018
The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study
2017 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Andrew P. Crew 3015 352 223 1148 958 37 3.5k
John Hines 4019 338 110 1669 1205 42 4.4k
Katherine A. Donovan 3107 199 156 1291 802 83 3.4k
George M. Burslem 2691 418 105 1068 681 52 3.1k
Hanqing Dong 3374 1045 210 1276 951 51 4.7k
Radosław P. Nowak 3064 199 138 1122 648 67 3.5k
Daniel K. Treiber 2510 281 126 554 437 24 3.2k
Joshiawa Paulk 3277 134 79 976 833 18 3.5k
Dennis L. Buckley 5576 263 144 1687 1340 35 6.0k
Frank Boschelli 1354 643 127 570 802 68 2.6k
Patrick P. Zarrinkar 3326 426 203 718 1263 34 4.8k

All Works

Loading papers...

Rankless by CCL
2026